Period Ending | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 |
---|
Total Revenue
|
3,404,000
|
3,398,000
|
3,277,000
|
3,379,654
| Cost of Revenue | 1,022,000 | 987,000 | 983,000 | 1,034,184 | |
Gross Profit
|
2,382,000
|
2,411,000
|
2,294,000
|
2,345,470
| |
|
Operating Expenses |
|
Research Development | 389,000 | 394,000 | 374,000 | 344,171 |
|
Selling General and Administrative | 1,243,000 | 1,238,000 | 1,183,000 | 1,162,925 |
|
Non Recurring |
-
|
-
|
-
| (489) |
|
Others | 83,000 | 84,000 | 84,000 | 85,374 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| 1,591,981 | | |
Operating Income or Loss
|
667,000
|
695,000
|
653,000
|
753,489
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 74,000 |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 672,000 | 851,000 | 684,000 | 2,435,046 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 672,000 | 851,000 | 684,000 | 2,435,046 |
|
Income Tax Expense | 75,000 | 159,000 | 114,000 | 455,659 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 597,000 | 692,000 | 570,000 | 1,979,387 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
597,000
|
692,000
|
570,000
|
1,979,387
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
597,000
|
692,000
|
570,000
|
1,979,387
|
|